Skip to main content
INO
NASDAQ Life Sciences

Inovio Extends Expiration of Warrants for 13.5M Shares, Prolonging Potential Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$1.52
Mkt Cap
$105.116M
52W Low
$1.3
52W High
$2.979
52W Position info
17% above low
Off High info
49% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

INO sits 17% above its 52-week low of $1.3 on light trading volume (0.3× avg).

Summary

Inovio Pharmaceuticals extended the expiration date of its Series A warrants, exercisable for up to 13.56 million shares at $1.75 each, from January 28, 2026, to March 31, 2026.


Key Events · Financing and Capital Events · INO

  • Warrant Expiration Extended

    The expiration date for 13,564,268 Series A warrants was extended from January 28, 2026, to March 31, 2026.

  • Significant Potential Dilution

    These warrants are exercisable at $1.75 per share, representing a potential capital raise of approximately $23.7 million and significant dilution if exercised.


Analysis · INO · Life Sciences

This extension of Series A warrants, which could result in the issuance of over 13.5 million shares, prolongs the potential for significant dilution for existing shareholders. While the warrants are currently out-of-the-money (exercise price $1.75 vs. current stock price $1.52), the company aims to provide more time for the stock price to potentially rise, increasing the likelihood of warrant exercise and thus capital inflow. The potential capital raise of approximately $23.7 million, if all warrants are exercised, represents a substantial amount relative to the company's market capitalization. This move highlights the company's ongoing efforts to secure financing, but also maintains an overhang of potential dilution.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, INO was trading at $1.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $105.1M. The 52-week trading range was $1.30 to $2.98. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

INO - Latest Insights

INO
Nov 10, 2026, 4:05 PM EST
Source: PR Newswire
Importance Score:
7
Price at Filing: $1.46
Real-time Price: $1.64 info
Change: +$0.175 (+12%) info
Market Cap: $305.31M info
INO
Nov 10, 2026, 4:01 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $1.64 info
Change: +$0.165 (+11%) info
Market Cap: $305.31M info
INO
Nov 09, 2026, 7:30 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.37
Real-time Price: $1.64 info
Change: +$0.265 (+19%) info
Market Cap: $305.31M info
INO
Nov 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.21
Real-time Price: $1.64 info
Change: +$0.425 (+35%) info
Market Cap: $305.31M info
INO
Nov 05, 2026, 11:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.23
Real-time Price: $1.64 info
Change: +$0.4056 (+33%) info
Market Cap: $305.31M info